96. クローン病 Crohn disease Clinical trials / Disease details

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

29 trials found

diseases per page:

Showing 1 to 10 of 29 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05386290 (ClinicalTrials.gov)	July 9, 2020	17/5/2022	A Multicentered Prospective Cohort Study of Chinese IBD Patients	A Multicentered Prospective Cohort Study of Chinese IBD Patients Concerning Cost-effectiveness Analy ...	Ulcerative Colitis;Crohn Disease	Drug: Infliximab;Drug: Vedolizumab;Drug: Ustekinumab;Drug: conventional treatment (glucocoticoid, im ...	Peking Union Medical College Hospital	NULL	Enrolling by invitation	14 Years	80 Years	All	200		China
2	EUCTR2018-001382-17-GB (EUCTR)	30/10/2018	24/06/2019	An investigational study to assess the safety and effectiveness of continuing existing 5-ASAmedicati ...	Stopping Aminosalicylate Therapy in Inactive Crohn’s Disease (STATIC) Study: A Randomized, Open-labe ...	Inactive Crohn’s Disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]	INN or Proposed INN: MESALAZINE	Alimentiv Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1580	Phase 4	Canada;United Kingdom
3	NCT02769494 (ClinicalTrials.gov)	March 2016	9/3/2016	The Efficacy of Topical MesalazineSustained-Release Tablets in Crohn's Disease Patients With Oral Ul ...	The Efficacy of Topically Applied MesalazineSustained-Release Tablets in Oral Lesions of Crohn's Dis ...	Crohn's Disease;Oral Ulcer	Drug: Mesalazine Sustained-Release Tablets;Drug: Riboflavin Sodium Phosphate Injection	Xijing Hospital of Digestive Diseases	NULL	Withdrawn	18 Years	65 Years	All	0	Phase 3	China
4	NCT02335281 (ClinicalTrials.gov)	January 2015	7/1/2015	Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease	Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation for Severe Inflamma ...	Inflammatory Bowel Disease;Ulcerative Colitis;Crohn's Disease	Procedure: FMT;Drug: Mesalazine	Yanling Wei	NULL	Recruiting	16 Years	70 Years	Both	40	Phase 2	China
5	NCT02044952 (ClinicalTrials.gov)	January 2014	19/1/2014	Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Inductio ...	Prospective Experimental of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction ...	Inflammatory Bowel Diseases;Crohn's Disease;Gastrointestinal Diseases;Digestive System Diseases;Inte ...	Drug: Mesalazine , Tripterygium glycosides	Zhu Weiming	NULL	Recruiting	18 Years	75 Years	Both	40	Phase 2/Phase 3	China
6	NCT01696942 (ClinicalTrials.gov)	February 2013	25/9/2012	Cimzia Versus Mesalamine for Crohn's Recurrence	Use of Certolizumab Following Ileocolectomy Lowers Endoscopic and Histological Recurrence Rates for ...	Crohn's Disease	Drug: Cimzia;Drug: Mesalamine	Milton S. Hershey Medical Center	UCB Pharma	Terminated	18 Years	N/A	All	10	Phase 4	United States
7	NCT01514240 (ClinicalTrials.gov)	February 2012	10/1/2012	Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan	A Multicentre, Double-blind, Randomised, Parallel-group, Phase III Study to Assess Efficacy and Safe ...	Crohn's Disease	Drug: D9421-C capsule 3 mg;Drug: Mesalazine tablets	AstraZeneca	NULL	Completed	15 Years	130 Years	All	123	Phase 3	Japan
8	EUCTR2009-011220-62-NL (EUCTR)	26/10/2009	13/07/2009	A randomized controlled withdrawal trial in Crohn's disease patients in long-term remission on mesal ...	A randomized controlled withdrawal trial in Crohn's disease patients in long-term remission on mesal ...	1. Patients with a diagnosis of quiscent (CDAI < 150) Crohn's Disease (CD) according to established ...	Product Name: mesalazine INN or Proposed INN: mesalazine Other descriptive name: AMINOSALICYLIC ACID	University Medical Center Utrecht	NULL	Not Recruiting			Female: yes Male: yes			Netherlands
9	NCT00862121 (ClinicalTrials.gov)	April 2009	13/3/2009	A Study With Pentasa in Patients With Active Crohn's Disease	PENTASA in Active Crohn's Disease: A 10-week, Double-blind, Multi-centre Trial Comparing PENTASA Sac ...	Crohn´s Disease	Drug: Pentasa;Drug: Placebo	Ferring Pharmaceuticals	NULL	Terminated	18 Years	N/A	All	20	Phase 3	United States;Belgium;Denmark;France;Germany;Sweden;United Kingdom;Spain
10	NCT00245505 (ClinicalTrials.gov)	February 2009	26/10/2005	The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active Drug: Crohn's Disease	The Effect on Mucosal Healing With Pentasa Sachet 4g in Mild to Moderate Active Small Bowel Crohn´s ...	Crohn's Disease	Drug: Mesalazine (Mesalamine)	Ferring Pharmaceuticals	NULL	Terminated	18 Years	70 Years	Both	3	Phase 3	Sweden

First Previous1 2 3Next Last